The Vilsmeier-Haack reaction of active methylene compounds led to the formation of b-halo carbaldehydes, which constitute a class of compounds that served as useful intermediates towards construction of different heterocyclic compounds (1). Accordingly, some of b-chlorocarbaldehydes were described to react with phenylhydrazine and 2-mercapto acetic acid and its ethyl ester to give the corresponding pyrazolo and thieno derivatives (2-6). Pawar and Rajput (7) reported the synthesis of 5-anilinothiazolo- [5,4-d]isoxazole from 4-chloro-2-anilinothiazol-5-carbaldehyde with hydroxylamine hydrochloride. As it is known, oxime ethers have found many uses in recent years as nonsteroidal anti-inflammatory drugs (8), insect growth regulators (9), materials with steroidal effect (10), and as antimicrobial agents (11).
EXPERIMENTAL
Melting points were determined in open glass capillaries using an Electrothermal IA 9000 SERIES digital melting point apparatus (Electrothermal, UK) and are uncorrected. Microanalyses were performed with all final compounds on an Elementar-Vario EL (Elementar-Vario EL, Germany) (Microanalytical Unit, Central Services Laboratory, National Research Centre, Cairo, Egypt). The NMR spectra were recorded on a Varian Mercury VX-300 NMR spectrometer (Varian, USA). 1 H NMR spectra were run at 300 MHz in CDCl 3 as solvent. Chemical shifts d are quoted in ppm and were related to that of the solvents. Mass spectra were recorded on a Shimadzu GCMS-QP 1000EX (EI, 70 eV) (Shimadzu, Japan) and Hewlett-Packard (EI, 70 eV) (Hewlett-Packard, USA). IR spectra were obtained with a Brucker-Vector 22 (Bruker Rhein-Stetten, Germany) for neat samples (for liquids) or KBr wafers (for solids).
2,3-Dihydro-2,2-dimethylchromen-4-one (1a) (12), 2,3-dihydro spirochromen(2,1') cyclohexane-4-one (1b) (13), 2,3-dihydro-2-ethyl-2-methylchromen-4-one (1c) (12) , 4--chloro-2,2-dimethyl-2H-chromene (2a) (14) , 4-chloro spiro-2H-chromene(2,1')cyclohexane (2b) (15), 4-chloro-2-ehyl-2-methyl-2H-chromene (2c) (16), 4-chloro-2,2-dimethyl-2H--chromene-3-carbaldehyde (3a) (6), 4-chloro spiro-2H-chromene(2,1')cyclohexane-3-carbaldehyde (3b) (6) , and 4-chloro-2-ethyl-2-methyl-2H-chromene-3-carbaldehyde (3c) (16) were prepared according to the literature.
Syntheses
Reaction of b-chlorocarbaldehyde 3c with hydrazine hydrate. -Hydrazine hydrate (0.10 mL, 2.50 mmol) was added to a solution of b-chloro carbaldehyde (3c) (0.60 g, 1.25 mmol) in 99% ethanol (10 mL). The reaction mixture was refluxed for 3 h, the formed solid was filtered and crystallized from ethanol to give the corresponding aldazine RS N,N´-bis- [ 
1-(4-chloro-2-ethyl-2-methyl-2H-chromen-3-yl)methylidene]-hydrazine (4).
Reaction of b-chlorocarbaldehyde 3c with arylhydrazine. -Arylhydrazine (2.5 mmol) was poured into a solution of b-chlorocarbaldehyde (3c) (0.6 g, 2.5 mmol) in 99.7% acetic acid (15 mL). The reaction mixture was refluxed for 3 h and then evaporated under reduced pressure. The residue was treated with dichloromethane, then the formed solid was filtered off, which, identified as arylhydrazine, and the filtrate was washed with 5% aqueous NaHCO 3 and water, dried over Na 2 SO 4 , and evaporated to dryness. The residue was triturated with EtOH (few mL), the yellow solid was filtered off to give the corresponding hydrazones 5a,b.
Reaction of b-chlorocarbaldehydes 3a-c with thiosemicarbazide. -A mixture of b-chlorocarbaldehyde (3a, 3b or 3c) (2 mmol) and thiosemicarbazide (0.18 g, 2 mmol) in 99.7% acetic acid (15 mL) was refluxed for 3 h and then evaporated under reduced pressure. The residue was dissolved in dichloromethane, and the resulting solution was washed with 5% aqueous NaHCO 3 and water. The organic phase was dried over Na 2 SO 4 and evaporated to dryness. The crude product was purified by column chromatography on silica gel (Merck 60, particle size 0.06-0.20 mm); chloroform was used as an eluent to afford the corresponding thiosemicarbazones 6a-c.
Reaction of b-chloro carbaldehydes 3a-c with hydroxylamine hydrochloride. -Hydroxylamine hydrochloride (0.2 g, 3 mmol) was added to a solution of b-chlorocarbaldehyde (3a, 3b or 3c) (3 mmol) in absolute ethanol (50 mL) containing triethylamine (3 mL). The reaction mixture was refluxed for 5 h, and then the solvent was evaporated under reduced pressure. The residue was dissolved in chloroform and washed with water 3 times. The organic layer was dried over Na 2 SO 4 and evaporated under reduced pressure to afford the corresponding oximes 7a-c as crude products. The pure oximes 7a-c were obtained after additional purification by column chromatography on silica gel (Merck 60, particle size 0.06-0.20 mm); petroleum ether 60-80°C/ether (20:1, V/V) was used as an eluent.
Reaction of 4-chloro-2,2-substituted chromeno-3-aldoximes 7a,b with acyl chlorides or ethyl chloroacetate. -An appropriate acyl chloride (acetyl chloride, chloroacetyl chloride, benzoyl chloride) or ethyl chloroacetate (3 mmol) was added to a solution of 4-chloro-2,2--substituted chromeno-3-aldoxime (7a or 7b) (3 mmol) in dry toluene (20 mL) containing redistilled dry pyridine (0.25 mL, 3 mmol). The reaction mixture was refluxed for 5 h, then cooled and extracted with water; the toluene solution was dried over calcium chloride. The solvent was evaporated under reduced pressure to give the corresponding oxime ethers 8a-h, respectively.
Pharmacology
Newly synthesized benzopyran derivatives were dissolved in 0.5% carboxymethyl cellulose (CMC) and administered intraperitonneally (i.p.), at a dose of 5 mg kg -1 body mass.
Wistar albino mice 3 months, 20 g body mass and Sprague Dawley rats (3 months, 100 g body mass) of either sex (National Research Centre, Giza, Egypt) were housed under suitable laboratory conditions (30°C, RH 55%) throughout the investigation period. Animals were fed standard pellet chow (El-Nasr Chemical Company, Cairo, Egypt) and allowed free access to water.
All animal procedures were performed after approval from the Ethics Committee of the National Research Centre and in accordance with the recommendations for the proper care and use of laboratory animals (NIH publication No. 85-23, revised 1985).
Anti-inflammatory activity. One hundred and eight rats were divided into eighteen groups, each group consisting of six animals. Anti-inflammatory activity of the compounds under investigation was studied in rats using carrageenean. A suspension of the tested compound and of the reference drug indomethacin in aqueous CMC solution (0.5%, m/V) was administrated orally to rats at a dose level 5 mg kg -1 b. m. Control animals were treated with 0.5% CMC only. After 30 min, 0.1 mL of freshly prepared 1.0% carrageenean solution (in sterile 0.9% NaCl) was injected into the subplantar region of the right hind paw according to the method of Hernands-Perez et al. (17) . The right paw volume was measured using a digital plethysmometer 7150 (Ugo Basile, Italy) directly before and after 1, 2, 3 h intervals after administration of the tested compounds.
Ulcerogenic activity
Seventy-two rats were divided into twelve groups, each group consisting of six animals according to reported procedure (18) . Ulcerogenic activity was evaluated after p.o. administration of the tested compounds or indomethacin at doses of 10, 50, and 100 mg kg -1 b. m. Control rats received vehicle per os (0.5% CMC). Food but not water was removed 24 h before administration of the tested compounds. After 6 h, the rats were sacrified, the stomach was removed and opened along the freater curvature, washed with distilled water and cleaned gently by dipping in saline. The mucosa damage for each stomach was examined using a stereoscopic microscope (Nikon SMZ 1B stereoscopic microscope, Nikon USA) and compared with indomethacin.
Acute toxicity
The median lethal doses (LD 50 ) of the most active compounds 6a-c were determined in mice (19) . Groups of male adult mice, each of six animals, were injected i.p. with graded doses of each of the test compounds. The percentage of mortality in each group of animals was determined 24 h after injection. Computation of LD 50 was processed by a graphical method.
RESULTS AND DISCUSSION

Chemistry
The chromanone derivatives 1a-c were reacted with Vilsmeier reagent (DMF/ POCl 3 ) to give the corresponding 4-chlorochromene derivatives 2a-c along with 4-chloro (2H)chromene-3-carbaldehyde 3a-c according to Scheme 1.
When RS-4-chloro-2-ethyl-2-methyl(2H)chromene-3-carbaldehyde (3c) was treated with hydrazine hydrate in equimolar ratio 1:1 or in excess of hydrazine hydrate under reflux in ethanol, only the corresponding aldazine derivative 4 (Scheme 2) was separated and characterized by elemental analysis and spectral data (Tables I and II) . The IR spectrum of compound 4 showed C=N absorption at 1591 cm -1 , whereas 1 H NMR spectrum of 4 showed the methylidine proton at d 8.82 ppm. The mass spectrum of 4 showed a prominent ion peak M + at m/z 468 (5%).
Accordingly, RS-4-chloro-2-ethyl-2-methyl(2H)chromene-3-carboxaldehyde
(3c) reacted with 4-nitrophenylhydrazine and 2,4-dinitrophenylhydrazine to produce the corresponding hydrazone derivatives 5a,b (Scheme 2). 
Anti-inflammatory activity
The results of ant-inflammatory testing are listed in Table III , showing the percent inhibition of edema obtained by the reference drug and tested compounds, respectively. Results show that compounds 4, 5a,b, 7a,b,c and 8a,b,c,d possess weak anti-inflammatory activity (8-41% of inhibition) in comparison to that of indomethacin (42-62%). Compounds 6a, 6b and 6c showed activity of 35 to 62%, equal to that of indomethacin. The condensation of thiosemicarbazide group with carbaldehyde group in the pyrane ring increased the activity in all cases. Cyclohexyl group at position 2 in the pyrane ring was found to be less active compared to methyl and ethyl groups at position 2 in the pyrane ring (Table III) .
Ulcerogenicity and acute toxicity
Compounds 6a-c were screened for their ulcerogenic activity at dose levels of 10, 50 and 100 mg kg -1 b.m. (Table IV) . The Tested Compounds 6a-c Showed No Ulcerogenic Activity compared to indomethacin, which showed mean ulcerogenic activity of 1.4 to 2.1 mm.
Acute toxicity LD 50 of compounds 6a-c was found to be 145, 155 and 165 mg kg -1 (i.p.), respectively, whereas, LD 50 of indomethacin was 50 mg kg -1 (i.p.). 1-[(4-Chloro-2,2-dimethyl-2H-chromen-3-yl)methylene]thiosemicarbazide (6a), 1-[(4--chlorospiro-2H-chromen(2,1')cyclohexane-3-yl)methylene]thiosemicarbazide (6b) and 1-[(4-chloro-2-ethyl-2-methyl-2H-chromen-3-yl)methylene]thiosemicarbazide (6c) were found to be potent anti-inflammatory agents comparable to indomethacin. On the other hand, they show no ulcerative activity and higher LD 50 values than indomethacin. The thiosemicarbazide group at position 3 of the pyrane ring might be responsible for these activity.
